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Abstract
The resources for health technology assessment fall short of that needed to evaluate all
health technologies. Therefore, priorities have to be set. In The Netherlands, the Health Care
Insurance Board tried to address this issue by developing a more explicit priority setting
procedure for the Fund for Investigative Medicine, which is the most important health
technology assessment programme in The Netherlands. The procedure provides one of the
first examples of the application of theoretical principles for priority setting. The aim is to
select those health technologies for assessment that are most relevant for policy-making. To
determine the policy relevance of research proposals, different procedures for categorising,
scoring, and weighting policy criteria were defined, and different classification strategies were
explored. Our first experiences using the priority setting procedure are described by means of
an example on low back pain. Subsequently, the procedure has been applied to research
proposals submitted to the Fund for Investigative Medicine in 1998 to illustrate how
decisions on the funding of health technology assessments can be guided. The results show
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a different rating of research proposals into one of three predefined categories of policy
relevance, high, intermediate and low, implying that decisions about funding can heavily
dependent on the selected procedure. Therefore, it seems to be important that the selected
procedure reflects the viewpoint of the organisation wishing to set priorities. The different
ratings of the research proposals using a more explicit procedure suggest that there may be
scope for further development and application of the procedure. © 2002 Elsevier Science
Ireland Ltd. All rights reserved.
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1. Introduction
To date only a fraction of the existing health technologies have been evaluated
while many more new health technologies continue to be adopted without evalua-
tion. The resources to undertake health technology assessment (HTA) fall short of
that needed to evaluate all health technologies. This implies that priorities have to
be set. Several government agencies have tried to address this thorny issue,
especially in the US, UK, and in Spain. Although the resulting publications [1–8]
generally emphasise the importance of focusing on societal or policy relevance, the
feasibility of the methods proposed has been insufficiently evaluated, thus preclud-
ing firm conclusions about their usefulness [9].
In The Netherlands, the Health Care Insurance Board also tried to address
priority setting for HTA. The Board aims to stimulate a more evidence-based use
of social health insurance resources. Among other activities, the Board adminis-
tered during the last decade the Fund for Investigative Medicine, which is the most
important HTA programme in The Netherlands. This Fund was established in 1988
with an annual research budget of approximately US $15 million1. Every year
actors in the health care field, with a strong emphasis on university hospitals, are
invited by the Health Care Insurance Board to submit research proposals focusing
on new or existing health technologies. The projects are commissioned to provide
information for evidence-based policy making on the governmental level and
should also promote evidence-based use of the relevant health technologies at the
practice level. For advising the Minister of Health on funding of research proposals
within this Fund, a special Committee for Investigative Medicine was installed. The
members of the Committee are experts from the health care field and experts in
HTA.
In the conventional procedure to evaluate research proposals, two reviewers of
the Committee for Investigative Medicine and two reviewers of the Secretariat of
the Committee, who are policy advisors of the Health Care Insurance Board, judge
the policy relevance of submitted research proposals in qualitative terms. The
reviewers judge, independently, whether the proposals fit within the scope and
1 Since 2000 the Council for Medical and Health Research (MW-NWO, recently changed into
ZonMw) administers the Fund for Investigative Medicine (changed into Health Care Efficiency Research
Programme). Its annual budget has been decreased to about 7 US $ million a year.
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purpose of the Fund, and assess their policy relevance. Reviewers are asked to
express their judgement in a score, ranging from 1 (no policy relevance) to 10 (very
high policy relevance). In a meeting of the Committee for Investigative Medicine
the arguments of the reviewers are discussed and a summary judgement of each
proposal is made. Proposals with intermediate or high policy relevance subse-
quently are sent to the Council for Medical and Health Research (MW-NWO,
recently changed into ZonMw) for a thorough appraisal of scientific quality. The
Council for Medical and Health Research was installed in 2000, when the Board for
Medical Science of The Netherlands Organisation for Scientific Research, (Gebieds-
bestuur Medische Wetenschappen-MW-NWO) became part of the Health Research
and Development Council (ZorgOnderzoek Nederland). The Ministry of Health
and The Netherlands Organisation for Scientific Research initiated the Council,
which is responsible for programming, priority setting and the actual allocation of
government funds regarding the whole spectrum between basic health research and
health care practice. Based on the (qualitative) judgements of policy relevance and
scientific quality projects can be either accepted, turned down, or be deemed eligible
for resubmission and reappraisal. Although acceptable scientific quality is, of
course, a necessary condition for funding, this part of the procedure falls outside
the scope of this article.
The conventional procedure was mainly implicit. Our idea was that explicit use
of objective (quantifiable) information would make priority setting more transpar-
ent, robust and evidence-based. In different reports the Health Care Insurance
Board has described criteria for identifying the relevance of HTA for policymaking,
such as burden of disease and costs of the intervention under study [10,11].
However, addressing these criteria explicitly in the grant application form was not
required until 1998, when a more explicit and detailed procedure was introduced. In
this paper, we describe the first experiences using a new priority setting procedure
by means of an example on low back pain. Subsequently, the procedure has been
applied to all eligible research proposals submitted to the Fund for Investigative
Medicine in 1998 to illustrate how real-world choices on funding of health
technology assessments can be guided.
2. Methods
As recommended in the EUR-ASSESS report on priority setting for HTA,
possible assessments should be rated in a systematic way using explicit criteria [9].
In the literature the following broad categories of criteria for determining societal
relevance are mentioned: (1) number of people affected; (2) expected effectiveness;
(3) economic consequences and (4) potential impact on health policy [3,12,13].
These categories can each consist of one or more criteria, depending on the
perspective of those wishing to set priorities. The Health Care Insurance Board is
restricting societal relevance to policy relevance from their perspective, which was
defined according to the following criteria, which are similar to those mentioned in
the literature:
W.J. Oortwijn et al. / Health Policy 62 (2002) 227–242230
(A) Actual burden of disease, given current treatment strategies for the individual
patient;
(B) Potential benefit for the individual patient;
(C) Number of patients;
(D) Direct costs of the intervention per patient;
(E) Financial consequences of applying the intervention over time (impact on
total costs of health care);
(F) Additional aspects, with an impact on health policy (for example, rapid
uncontrolled diffusion).
2.1. Priority setting procedure
In the new priority setting procedure, the reviewers evaluated the proposals using
objective data on policy relevance stated in the research proposals. Researchers
submitting research proposals are explicitly requested in the application form to
provide (preferably quantitative) information about the policy relevance of the
proposed research project. In the review process the reviewers fill out an evaluation
form, in which they use the information provided by the researchers. A rating
procedure to determine the policy relevance of research proposals was proposed by
an independent researcher (WO). Since there is no ‘gold standard’ for priority
setting for HTA, each step in the procedure was thoroughly discussed with the
Committee for Investigative Medicine. The final procedure, which was approved by
the Committee, consists of the following steps.
2.1.1. Categorisation and scoring of criteria
Starting from the six policy criteria mentioned above, ways to categorise and
score criteria were defined. Categorical scales for scoring each criterion were
devised. The choice for these categorical scales was partly based on the methods
employed by the National Institute for Health and Environment—Rijksinstituut
voor Volksgezondheid en Milieu (RIVM) for expressing disease severity and cost of
illness [14–16]. The RIVM collects basic data relating to the health of the Dutch
population and the functioning of the health care system. The RIVM calculated the
burden of disease in terms of disability-adjusted life years (DALYs) lost for a
number of diseases as part of a report on the present and future public health status
in The Netherlands [14]. For this purpose, severity weights of each selected disease
were determined on a scale between 0 and 1 by means of applying the Person
Trade-Off (PTO) methodology [16]. The procedure used by RIVM applies mainly
to criteria A (actual burden felt by the patient–disease severity) and B (potential
benefit). In the literature we did not find any indications for determining priority
order of the remaining criteria. For reasons of discrimination and comparability a
scale with five categories (scores ranging from 1 to 5) was used to score each of the
six policy criteria for each research proposal (Table 1).
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Table 1
Definition and scoring of policy criteria
Criterion ScoreMeasured with
(A) Actual burden of disease, given current Rating scale (0–1.00), 0 represents the
highest burden of disease and 1.00treatment strategies






(B) Potential benefit for the individual Rating scale (0–1.00), 0 represents no
potential health benefit and 1.00 representspatient













US $(D) Direct costs of intervention per patient




6000 US $ 5
Qualitative estimation(E) Financial consequences
1High potential increase in costs
2Little potential increase in costs
3Cost neutrality
4Little potential decrease in costs
5High potential decrease in costs
Number of aspects(F) Additional aspects with an impact on





5Four or more than four aspects
2.1.2. Rating of criteria
The second step aimed to achieve an overall rating of research proposals into the
categories high, intermediate and low policy relevance. Alternative algorithms for
arriving at a judgement on the policy relevance of a proposal were studied,
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including varying total scores that can be used as cut-off points to distinguish
between high, intermediate and low policy relevance. We first used a simple additive
procedure for reasons of practicability. In this procedure the total score (TS) was
calculated on the basis of the formula: TS (A+B+C+D+E+F), where A–F
reflect the score of each criterion. This implied that the total score of a research
proposal could range between a minimum score of 6 (if all 6 criteria were assigned
the minimum score of one) and a maximum score of 30 (if all 6 criteria were
assigned the maximum score of 5) (Table 1). In this procedure no weighting
methods were used, implying that all criteria are equally important. This procedure
was called ‘non-weighted procedure’.
2.1.3. Weighting the criteria
The third step of developing an explicit procedure focused on weighting the
various criteria [3]. Three of the six criteria (A–C) reflect the potential effects on
health, while two of the six criteria (D–E) reflect the potential effects on costs and
only one criterion (F) reflects additional aspects relevant for health policy. The
focus of attention now has changed from individual criteria (A, B, C, D, E and F)
to categories of criteria (category I, effects on health including criterion A, B and
C; category II, effects on costs, including criterion D and E, and category III,
including only criterion F, additional effects on health policy). Since all criteria are
combined in an overall score (TS) in the ‘non-weighted procedure’, this distribution
implies that the issue regarding effects on health is represented to a larger extent in
the overall score than the other two issues. Therefore, it was decided to examine the
effects of employing two alternative weighting algorithms within the priority setting
procedure.
In the first instance, the scores of the three categories (I, II and III) received the
same value, meaning that they are equally important. Therefore, this procedure was
called the ‘equal weights procedure’. As a consequence, the following formula was
used for calculating total scores: TS= (A+B+C)+ (1.5(D+E))+ (3F). This
implied that the total score of a research proposal could range between a minimum
of nine and a maximum of 45.
For the second algorithm, the relative importance of the potential effects and
costs (categories I and II) received equal weighting, while the criterion ‘additional
aspects with an impact on health policy’ (category III) received a lower weighting
rate. This procedure was called ‘different weights procedure’. In this procedure the
total score was based on the formula: TS= (A+B+C)+ (1.5(D+E))+ (F). This
implied that the total score of a research proposal could range between a minimum
of seven and a maximum of 35.
2.2. Classification of research proposals
To judge the policy relevance of research proposals submitted to the Fund for
Investigative Medicine the scores of (all three variants of) the priority setting
procedure had to be transformed into categories representing low, intermediate or
high policy relevance. Because of reasons of practical applicability two different
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Table 2
Procedure-specific range of scores and associated cut-off points
Policy relevanceProcedure
Relaxed strategy for policy relevanceStrict strategy for policy relevance
High Low IntermediateIntermediate HighLow
Non-weighted 17–23 24–30 6–10 11–18 19–306–16
35–45 9–15Equal weights 16–279–23 28–4524–34
28–35 7–12 13–2119–27 22–357–18Different weights
strategies were used. First, it was decided to take the same distribution of scores (1–4,
low; 5–7, intermediate and 8–10, high policy relevance) as used in the conventional
procedure. Therefore, the bottom 40% of the potential range in scores (maximum
score–minimum score) represented low policy relevance, the following 30% of the
potential range in scores represented intermediate policy relevance, and the highest
30% of the potential range in scores represented high policy relevance. This strategy
was called ‘strict strategy’. Secondly, a less strict classification scheme was chosen,
leading to the following distribution: the bottom 17% of the potential range in scores
represented low policy relevance, 33% of the potential range in scores represented
intermediate relevance, while the highest 50% of the possible range in scores
represented high policy relevance. This strategy was called the ‘relaxed strategy’.
Combining the three procedures for scoring and the two strategies for arriving at
a judgement on policy relevance allows for calculation of six sets of procedure-specific
ranges of scores and associated cut-off points between categories of policy relevance
(Table 2).
A comparison between the process of the conventional procedure and the new
priority setting procedure is given in the Fig. 1 below.
2.3. Research proposals
In 1998, 77 research proposals were submitted to the Fund for Investigative
Medicine, of which 66 (86%) met the inclusion criteria for Investigative Medicine.
Of these, 25 had to be excluded due to missing data in the research proposals necessary
for the priority setting procedure. Therefore, 41 (62%) research proposals were eligible
for the priority setting procedure. Most of these research proposals focused on
therapeutic interventions (78%), while 10% focused on diagnostics, 5% on preventive
procedures and 7% were meta-analyses. We applied the different steps of the priority
setting procedure to determine the policy relevance of all research proposals. To
demonstrate how each of the three procedures for scoring and each of the two
strategies for arriving at a judgement on policy relevance can guide decision making
in real practice we randomly selected the research proposal on low back pain as an
example.
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Fig. 1. Comparison of the conventional and the new priority setting procedure.
2.4. Background information of research proposal on low back pain
Low back pain (for which no specific cause could be determined) is a frequent
problem in many countries. In most cases pain will be reduced after a few weeks,
and then most people can perform their daily activities again. For some patients,
however, low back pain will become a chronic disease, with a marked impact on
functional status and increasing the costs for treatment. Results of previous studies
show that chronic low back pain is mainly determined by psychological and social
factors. In the proposed study current practice will be compared with a ‘minimal’
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intervention, which consist of an initial consult of 20 min, given by a general
practitioner, and one or two follow up consults of 10 min. These consults are
focusing on psychological and social aspects with regard to low back pain.
General practitioners will be trained and supported for this purpose. In current
practice, general practitioners follow a guideline for treating patients with low
back pain, which is produced by the national organisation of general practi-
tioners. The central research question of this proposal is: is the functional status
of high-risk patients with low back pain improved after a ‘minimal’ intervention
of the general practitioner as compared with current practice? The primary out-
come measure used is functional status after 6, 12, 26 and 52 weeks. Functional
status is measured by specific measures of functional impairment due to low back
pain, recovery experienced by patients themselves, intensity of pain, severity of
the most important complaint and productivity losses. The secondary outcome
measure is cost-effectiveness of the experimental intervention compared with cur-
rent practice.
2.5. Policy releance of the research proposal
The following information concerning the six policy criteria (A–F) was stated
in the research proposal.
2.5.1. Effects on health (A–C)
The patient population includes all new patients with low back pain. The
proposal is focusing on those patients who have a high risk for chronic low back
pain. The incidence of low back is 36 per 1000 patients registered per year in
general practices in The Netherlands. Of the patients 60% still have complaints
after 4 weeks. Of these patients, 33% is at high risk for chronic low back pain.
This results in seven per 1000 high-risk patients. The minimal treatment aims to
prevent chronic low back pain by stimulating functional recovery and pain relief.
This will lead to a reduction in sick leave and will reduce referrals to physiother-
apists, manual therapists or to a pain centre as compared with current practice.
In current practice 60% of all new patients with chronic low back pain are
referred to a physiotherapist.
2.5.2. Effects on cost (D–E)
Direct costs are cost of diagnosis and of treatment of low back pain. The
mean direct costs per patient are 1500 $ US per year. Indirect costs are costs of
productivity losses. The mean indirect costs per patient are 12 000 $ US per year.
The costs of the new intervention (developments costs and costs of implementa-
tion) are probably low. The researchers expect a decrease in the number of
consults of general practitioners, in the number of referrals (to a physiotherapist
and pain centres), and in the number of subscriptions of pharmaceuticals to relief
pain. The researchers expect that the total costs can be reduced by 33%.
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2.6. Additional aspects with an impact on health policy (F)
Researchers are, for example, requested to state whether their subject of study is
on a published list of topics that should be given priority as identified by the Health
Care Insurance Board [17]. The Health Care Insurance Board describes low back
pain as one of the research areas in need of assessment. In addition, the potential
of the study to increase the cost-effectiveness of the Dutch health care is described
as well.
3. Results
3.1. Application of the priority setting procedure
We applied the different steps of the priority setting procedure to determine the
policy relevance of the research proposals under study. The application is illustrated
by means of the research proposal on low back pain.
3.1.1. Step 1, scoring of criteria
Four independent reviewers (two experts from the Committee for Investigative
Medicine and two policy advisors of the Health Care Insurance Board) scored the
policy criteria on an evaluation form. All scores were discussed in a meeting of the
Secretariat of the Committee for Investigative Medicine. In this meeting, a sum-
mary judgement was made for all policy criteria based on the mean score from all
evaluation forms. Information for criterion A is described qualitatively in the
research proposal (‘having pain and being limited in performing daily activities’). In
the summary judgement the actual burden of chronic low back pain was given a
score between 0.61 and 0.80 on a rating scale (0, highest burden; 100, lowest
burden). From Table 1 this measure results in a score of two for determining policy
relevance. The potential benefit for the individual patient (criterion B) is also
described qualitatively (‘the minimal intervention aims to prevent chronic low back
pain, resulting in functional recovery (defined as performing daily activities) and
pain relief’). The reviewers judged the presupposed benefits between 0.41 and 0.60.
This score on the rating scale results in a score of three for determining the policy
relevance of the research proposal. The number of patients involved (criterion C)
was calculated as seven per 1000 high-risk patients. If we take the number of
registered patients with low back pain per year in general practices (about 10% of
the total population— in 1997 about 14.2 million) it can be calculated that the
absolute number of high-risk patients with low back pain per year is about 10 000.
This evidence resulted in a score of two for calculating the policy relevance (Table
1). The direct costs of the intervention per patient (criterion D) were given in the
research proposal (1500 US $), which led to a score of one. The financial
consequences (criterion E) of the project were described qualitatively (‘decrease in
the number of consults of general practitioners, in the number of referrals (to a
physiotherapist and pain centres), and in the amount of pharmaceuticals to relief
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Table 3
Score of a proposal for treatment of low back pain using three procedures
Algorithm Actual total scoreRange of scoreProcedure
TS= (A+B+C+D+E+F) 6–30 17Non-weighted
289–45TS= (A+B+C)+(1.5(D+E))+(3F)Equal weights
Different weights 20TS= (A+B+C)+(1.5(D+E))+(F) 7–35
pain. The total costs of low back pain can be reduced by 33%.’). The reviewers
judge this information as a high potential decrease in costs, resulting in a score of
five. The final criterion (F) is focused on the additional aspects with an impact on
health policy. This criterion cannot be measured in quantitative measures, and is
therefore qualitative described in the research proposal (‘Low back pain is of high
interest to policy makers in The Netherlands. In documents produced by the
Ministry of Health low back pain is listed as one of the research areas in need of
assessment. In addition, low back pain is also a high priority to the Health Care
Insurance Board’). The reviewers mentioned three aspects, resulting in a score of
four. We used this information to determine the policy relevance of the three
different procedures for weighting as described below.
3.1.2. Step 2, rating of criteria
Based on the ‘non-weighted procedure’ (TS=A+B+C+D+E+F) the re-
search proposal on minimal treatment of low back pain received a total score of 17
(range of 6–30) (Table 3).
3.1.3. Step 3, weighting the criteria
Two alternative weighting algorithms that were used are the ‘equal weights
procedure’ and the ‘different weights procedure’. The total score has been calcu-
lated based on these alternative procedures as well, and are also presented in Table
3.
3.2. Oerall judgement on policy releance
To determine whether the research proposal should be granted or not, the actual
total scores of the research proposal on all three variants of the priority setting
procedure had to be transformed into categories representing low, intermediate or
high policy relevance. For this purpose the cut-off points of the ‘strict’ and ‘relaxed
strategy’ were used. Using the ‘strict strategy’ the research proposal was determined
to have intermediate policy relevance in all three procedures. However, in the
‘non-weighted procedure’ and the ‘different weights procedure’ the total score of
the research proposal was very close to the range of being classified as having low
policy relevance. When we used the ‘relaxed strategy’ a different classification
resulted. Within the ‘non-weighted procedure’ and the ‘different weights procedure’
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Table 4
Policy relevance of a research proposal on low back pain
Procedure Policy relevance
Relaxed strategy for policy relevanceStrict strategy for policy relevance




the research proposal was classified as having intermediate policy relevance, al-
though the total score was very close to the range of high policy relevance. In the
‘equal weights procedure’ the research proposal was classified as having high policy
relevance. The overall judgements of the research proposal are summarised in Table
4.
We used the same procedure for classifying all eligible research proposals that
were submitted to the Fund for Investigative Medicine in 1998. Table 5 shows the
number of proposals that were classified as having low, intermediate or high policy
relevance using the different classification strategies. The use of the ‘strict strategy’
implied that none of the research proposals was classified as having high policy
relevance. Most research proposals were classified as having low policy relevance,
meaning that these proposals would not be funded. When using the ‘relaxed
strategy’ most research proposals were classified as having intermediate policy
relevance, while only a small proportion was classified as having low policy
relevance. The impact of the different procedures for weighting the criteria on the
classification of research proposals is marginal.
Table 6 shows that only in a few cases (N=3, 7%) the choice of the procedure
for weighting the criteria and the choice of the ‘strict’ versus the ‘relaxed strategy’
Table 5
Policy relevance of all eligible research proposals (N=41) submitted to the Fund for Investigative
Medicine in 1998
Procedure Number of research proposals with low, intermediate or high policy relevance
Strict strategy for policy relevance Relaxed strategy for policy relevance
Low Intermediate High Low Intermediate High
26 632– 315Non-weighted
323 –Equal weights 18 1028
1922 11Different 2– 28
weights
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Table 6
Classification of all eligible research proposals into one or more categories of policy relevance using six
alternative priority setting procedures
Classification Number of proposals (percentage of
total, N=41) (%)
Low policy relevance in all procedures 2 (5)
1 (2)Intermediate policy relevance in all procedures
1 (2)Low policy relevance in five procedures, and
intermediate policy relevance in one procedure
4 (10)Intermediate policy relevance in five procedures, and low
policy relevance in one procedure
5 (12)Intermediate policy relevance in five procedures, and
high policy relevance in one procedure
3 (7)Intermediate policy relevance in four procedures, and
low policy relevance in two procedures
Intermediate policy relevance in four procedures, and 2 (5)
high policy relevance in two procedures
18 (44)Low policy relevance in three procedures, and
intermediate policy relevance in three procedures
5 (12)Intermediate policy relevance in three procedures, and
high policy relevance in three procedures
resulted in the same classification. The alternative procedures have, in particular, an
impact on the classification of research proposals as having low versus intermediate
policy relevance (N=18, 44%). As only research proposals with intermediate and
high policy relevance are sent to the Council for Medical and Health Research for
an appraisal of scientific quality, these results indicate that the priority setting
procedure may be critical for the funding of research proposals.
4. Discussion
We conclude that the use of alternative priority setting procedures resulted in a
different rating of a majority of the research proposals into the categories of low,
intermediate and high policy relevance. The different strategies result in different
decisions whether funding of HTAs can be justified or not.
In interpreting the value of the new procedure for priority setting for HTA,
various methodological aspects should be taken into consideration. Firstly, the
results show that the use of less strict cut-off points (‘relaxed strategy’) led to a
different distribution of research proposals in the three categories: low, intermediate
and high policy relevance. The impact of weighing is important in determining the
range of possible scores and therefore facilitates discrimination between proposals,
due to possibilities for scoring (scores differ between 6–30; 9–45 and 7–35). The
final decision about whether or not a research proposal should be granted is
therefore dependent on the strategy chosen. Secondly, it is important to identify
which actors will be involved in the priority setting procedure and what objectives
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need to be fulfilled. These objectives will determine the criteria needed to be taken
into account. Whether or not a priority setting procedure has to be set up by an
independent person, as done in our study, can be discussed. An advantage of
involving independent persons is that an influence of conflicts of interest can be
minimised. To ensure that priorities address questions of importance to policy it is
important to combine at least the perspectives of decision-makers and researchers.
In addition, in the case of the Health Care Insurance Board we could question
whether the scope of the priority setting procedure within the Fund for Investiga-
tive Medicine is not too narrow. The procedure excludes benefits to other sectors
than health care [18]. It is not clear whether inclusion of this aspect would change
the classification of research proposals, which needs further research in the future.
On the basis of this study, the Health Care Insurance Board adapted the
application form and the judgement forms for the new annual cycle in 1999 [19]. In
the new application form researchers are requested provide, preferably quantitative,
information about the policy criteria. They are also requested to justify quantitative
information by references. These changes are still used in the programme of
ZonMw, which administers the Fund for Investigative Medicine, changed into the
Health Care Efficiency Research Programme, since 2000 [20]. Our procedure for
priority setting for HTA was also selected for adaptation for the current develop-
ment of an Early Warning System for identification and assessment of new health
technologies in Denmark. From the first experiences it can be concluded that
adaptation of the priority setting procedure is feasible, but that there are some
methodological issues to be addressed [21].
The most important challenges resulting from this study concern methodological
issues such as defining suitable indicators and cut-off points for policy criteria. In
the context of the Fund for Investigative Medicine no obvious cut-off points were
described in the literature. Defining suitable criteria and cut-off points is strongly
dependent on the actors involved in the priority setting process. Those involved in
any HTA programme should be clear about how priorities will be identified and
who is responsible for which elements in the procedure. To date, the use of
weighting procedures in priority setting for HTA has hardly been studied. We are
aware of the fact that the scoring and weighting procedures used in the procedures
are not validated. Therefore, it is recommended to study the impact of different
ways of defining weighting factors and their impact on the final priorities for
funding research in more detail. The choice of scoring and weighing procedures is
dependent on the time available for developing a priority setting procedure and on
the practical applicability of the procedure chosen. Also, more research is needed to
assess the construct validity of the procedure, and to assess the influence of different
reviewers. One clear advantage of the priority setting procedure is that by using
evidence from research proposals for calculating priority scores, the procedure
becomes more transparent than using subjective judgements of reviewers only. An
important practical prerequisite for successfully applying the priority setting proce-
dure is that all necessary information needs to be available for scoring research
proposals, which is labour intensive. In our study we found that 25 out of 66
proposals (38%) had to be excluded due to missing data. Because of the lack of
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data, it is recommended to provide the applicants with clear information to ensure
that all questions will be answered and will be (more) evidence based. This will lead
to better quality of data for the priority setting process.
With limited resources, research should clearly be undertaken only on the basis
of those research proposals which contribute most to the objectives of the funding
organisation and which provide the maximum benefit for the limited resources
available [9; 18-19]. The use of explicit and transparent priority setting procedures
will certainly contribute to this. However, priority setting should not entirely be
based on policy relevance. Next to the policy relevance, other aspects such as the
scientific quality and the cost of research should also be taken into account when
actually funding proposals.
We conclude that this study provides one of the first examples of the application
of theoretical principles for priority setting for HTA in a real world setting. The
different prioritisation of the research proposals using the different procedures
suggests that there may be scope for further development and applications of a
more explicit priority setting procedure in different settings. As a minimum we
believe that this study strengthens the arguments for more explicit and transparent
procedures for setting priorities for HTA.
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